We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Company Seeks Court Relief for FDA Determination of Combination Product
Company Seeks Court Relief for FDA Determination of Combination Product
July 8, 2011
French manufacturer Prevor is suing the FDA claiming it overstepped its authority by naming Center for Drug Evaluation and Research (CDER) the primary review center, rather than CDRH, for the company’s combination product.